Cash Is Tight But Sales Are Fine
in Healthcare Providers

The short answer

Profit and cash diverge where downside risk on attributed lives is accepted before cost-per-episode data exist to set contract terms. For healthcare providers, this shows up in a particular place. The numbers that carry the answer are cost per episode and payer mix, and the complication specific to this industry is that downside risk has been accepted on 38,000 lives without the cost-per-episode data needed to price it. The general version of this problem and the one you are actually in have different first moves.

A provider with healthy contribution margins still loses cash when care is delivered under value-based contracts before payers settle, when panel size expands without matching cost-per-episode visibility, and when payer mix shifts toward contracts that pay after the episode rather than at the point of attribution.

Adding more attributed lives therefore widens the cash gap rather than closing it, because each new life under a value-based contract increases the volume of episodes whose costs are known only after the fact.

The direct levers are tighter submission of claims against attributed lives, negotiation of stage payments within value-based contracts, and reduction of panel size to the subset where cost-per-episode data already support pricing.

How to tell this is actually your problem

These three together are the signature. One on its own usually points somewhere else.

✓ Contribution per provider shows positive on the P&L while cash calls arrive from the same panel.
✓ Days between episode completion and payer remittance lengthen without any contract change being recorded.
✓ Each expansion of attributed lives under value-based contracts coincides with a tighter cash position.

The move that usually makes it worse. Borrowing to cover the gap while the cost-per-episode data and contract terms that created it remain unchanged.

Who this is for — and who it is not

It is for you if you run or finance a healthcare provider and the P&L looks healthy and the bank balance does not. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.

It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.

Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.

What this looks like when the analysis is actually run

Below is an excerpt from a real run of this analysis on a healthcare provider. It is a sample profile rather than a customer, and it is unedited engine output — this is the format you get, on your own numbers.

The subject is Cedar Ridge Health Partners, a sample company profile used for testing rather than a customer — 38,000 attributed lives under value-based contracts.

This is one move out of a full analysis. Read a complete report — every page, no email required.

What the engine does with this question

This question routes to Proprietary EFF Methodology, one of 29 engagements the platform runs. For healthcare providers it works through cost per episode, payer mix, panel size and contribution per provider, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.

You watch the analysis get built before paying anything. Read a complete report here if you would rather see the depth first.

Questions people ask about this

Why is my profitable business short of cash?

Because profit is recognised when you invoice and cash moves when people pay. The gap between those two, multiplied by growth, is the amount of cash your growth consumes.

What is the fastest way to release cash?

Usually invoicing latency and deposits, because both are within your control and take effect immediately. Chasing debtors helps and is slower; renegotiating supplier terms helps and is slower still.

Should I take financing to bridge it?

Only alongside closing the gap. Financing a structural working-capital cycle without changing the cycle means borrowing again at the next growth step, on worse terms.

Is this different in healthcare providers than in other industries?

Materially, yes. Downside risk has been accepted on 38,000 lives without the cost-per-episode data needed to price it — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are cost per episode, payer mix, panel size, and an answer built on industry-general benchmarks will usually point at the wrong one first.

What data do I need before this analysis is worth running for a healthcare provider?

Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on cost per episode and payer mix. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.

When is Percision the wrong tool?

Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.

Does Percision replace a lawyer, tax advisor, auditor, or AI implementation team?

Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.